HOUSTON, TX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Medical decisions about prescription weight-management treatments ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
Dec 12 (Reuters) - The U.S. health regulator on Friday approved Innoviva's (INVA.O), opens new tab oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an ...
FRANKFURT, Nov 18 (Reuters) - Roche's <ROG.S, opens new tab experimental oral drug giredestrant has been shown to cut the risk of recurrence of a common form of breast cancer after surgery, boosting ...
WASHINGTON ‒ President Donald Trump said he plans to develop a "Game 2 plan" to carry out his tariff agenda after a majority of Supreme Court justices expressed skepticism over his use of emergency ...
BEIJING, Nov. 4, 2025 /PRNewswire/ -- Grit Biotherapeutics Co., Ltd. ("Grit Bio"), a leading clinical-stage biopharmaceutical company pioneering next-generation immunotherapies, today announced that ...
Hosted on MSN
SBA wraps up NEEDs request presentations
Superintendents from around West Virginia had 10 minutes to pitch why their schools need money for repairs and renovations. ‘Predator: Badlands’ early reviews are all leaning one way Trump 'aware' ...
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist’s proprietary discovery platform are currently in advanced ...
WATERTOWN, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (LYRA) (Nasdaq: LYRA), (“Lyra” or the “Company”), a late clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback